Researchers have found in a new study that adding two percent crisaborole ointment to amorolfine hydrochloride cream ...

The time to onset of action was fastest with IL-17 inhibitors, followed by IL-23, IL-12/23, then PDE-4 and JAK inhibitors for PsO.

First FDA-approved medication for atopic dermatitis (eczema), plaque psoriasis, and seborrheic dermatitis to win prominent "Breakthrough Award” Allure Best of Beauty Breakthrough Award Winner ZORYVE ...

Posters support Ohtuvayre® (ensifentrine) as a first-in-class selective dual inhibitor of PDE3 and PDE4 for a broad COPD ...

CRD-750 is the first clinical-stage PDE9 inhibitor to be evaluated in patients in both types of chronic heart failure The CYCLE-1-REF trial is evaluating patients with heart failure with reduced ...

To date, benign diseases of the male and female lower urinary and genital tract, such as erectile dysfunction, bladder overactivity, lower urinary tract symptomatology secondary to benign prostatic ...

Eucrisa is a brand-name form of the generic medication crisaborole. Doctors prescribe it in topical form to help manage mild to moderate eczema. It belongs to a drug class called phosphodiesterase 4 ...

Introduction: Aortic Dissection (AoD) is the disruption in the layers of the aortic wall with bleeding into the medial layers. Aortic Aneurysm (AA) is a dilation of the aorta. One fatal consequence of ...

Carlsbad, CA, May 27, 2025 (GLOBE NEWSWIRE) -- Palisade Bio, Inc. (PALI) (“Palisade”, “Palisade Bio”, or the “Company”), a clinical-stage biopharmaceutical company focused on developing and advancing ...

The FDA announced a recall of ENDURANCE BOOST WITH HORNY GOAT WEED after it was found to contain undeclared ED drugs. These hidden ingredients can dangerously interact with nitrate medications, often ...

Health Fixer is recalling all lots of five male enhancement dietary supplements (Male Ultra, Malextra, Electro Buzz, Ultra Armor, and Male Ultra Pro) due to the presence of undeclared and potentially ...

The Phosphodiesterase (PDE) Inhibitors Market was valued at USD 2.82 billion in 2022, growing at a CAGR of 6.1% during the forecast period from 2023 – 2030. Owing to the surge in the poor lifestyle of ...